The activation of the inflammasome releases of substantial amounts of IL-1β and IL-18, which can damage pancreatic islets, exacerbate insulin resistance, and ultimately contribute to the development of T2DM [117]. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.